Arthritis Research & Therapy

official impact factor 4.36

Open Access

Impact of concomitant DMARD therapy on adherence to treatment with etanercept and infliximab in rheumatoid arthritis. Results from a six-year observational study in southern Sweden

Lars E Kristensen*, Tore Saxne, Jan-Åke Nilsson and Pierre Geborek

Arthritis Research & Therapy 2006, 8:R174 doi:10.1186/ar2084

Accesses  

  • Last 30 days: 45 accesses
  • Last year: 630 accesses
  • All time: 5343 accesses

Cited by

BioMed Central: 1 citation

Research article   Open Access

Medication persistence over 2 years of follow-up in a cohort of early rheumatoid arthritis patients: associated factors and relationship with disease activity and with disability

Virginia Pascual-Ramos, Irazú Contreras-Yáñez, Antonio R Villa, Javier Cabiedes, Marina Rull-Gabayet Arthritis Research & Therapy 2009, 11:R26 (19 February 2009)

Younger early rheumatoid arthritis patients are more persistent with medication than their older counterparts, meaning they reach sustained remission more quickly and benefit from reduced disease activity and disability levels.